Global Longlife Hospital and Research IPO offer price is ₹ 140.00 and got listed at ₹ 135.35. Read IPO details mentioned above.
Global Longlife Hospital and Research IPO listing price is ₹ 135.35, issue price is ₹ 140.00, and currently trading at ₹ 23.90 as on 5 march 2025. Infraprime Logistics IPO performance is show below with lates CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Global Longlife Hospital and Research IPO is a Fixed Price listing on BSE SME exchange. The company is based in Ahmedabad and caters to Healthcare - Hospitals And Clinic sector. Interactive Financial Services is the merchant banker of Global Longlife Hospital and Research IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 2nd March 2022.
Global Longlife Hospital and Research IPO offer price is ₹ 140.00 and got listed at ₹ 135.35. Read Infraprime Logistics Technologies IPO details mentioned above.Global Longlife Hospital and Research IPO, based in Ahmedabad, operates in the Healthcare - Hospitals And Clinic sector with a focus on Provides healthcare services. The company is launching its SME IPO on the BSE SME exchange, using the Fixed Price Issue method. Global Longlife Hospital and Research IPO size is ₹ 49.00 Cr. with fresh issue size of ₹ 49.00 Cr. and Offer for sale being Nil
The IPO allotment date for Global Longlife Hospital and Research IPO is expected to be 30th November -0001, after the finalization of basis of allotment. Investors can check Global Longlife Hospital and Research IPO allotment status on the registrars website, Bigshare Services Private Limited. Global Longlife Hospital and Research IPO refund dates are 30th November -0001.
Global Longlife Hospital and Research IPO is expected to be listed on 4th May 2022.
The upper price band for the Global Longlife Hospital and Research IPO is set at ₹ 140.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Global Longlife Hospital and Research IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Global Longlife Hospital and Research IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 25th April 2022. After submission, funds are blocked until the basis of allotment of Global Longlife Hospital and Research IPO is finalised.
The merchant banker for Global Longlife Hospital and Research IPO is Interactive Financial Services Limited . Interactive Financial Services Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Global Longlife Hospital and Research IPO RHP for further details.
The registrar for Global Longlife Hospital and Research IPO is Bigshare Services Private Limited. Investors can go to Bigshare Services Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Global Longlife Hospital and Research IPO through their official website or helpline.
Global Longlife Hospital and Research IPO was subscribed 1.50 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Listing Gain
Issue Price vs Listing Price:Market Performance
Issue Price vs CMP:Global Longlife Hospital and Research IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Global Longlife Hospital and Research Financial Review Page
Merchant Banker(s) of Global Longlife Hospital and Research IPO: Interactive Financial Services Limited
Global Longlife Hospital and Research IPO subscription was 1.50 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Global Longlife Hospital and Research IPO listed at a listing price of 135.35 against the offer price of 140.00.
The current market price of Global Longlife Hospital and Research is 23.90.
Why Us?